NGN Capital logo

NGN Capital

North America, New York, United States, New York

Description

NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.

Investor Profile

NGN Capital has made 38 investments, with 0 in the past 12 months and 47% as lead.

Stage Focus

  • Series B (34%)
  • Series C (26%)
  • Series A (16%)
  • Series Unknown (8%)
  • Series D (8%)
  • Post Ipo Equity (3%)
  • Private Equity (3%)
  • Series F (3%)

Country Focus

  • United States (74%)
  • Switzerland (16%)
  • Israel (5%)
  • Germany (5%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Therapeutics
  • Genetics
  • Health Diagnostics
  • Hospital
  • Industrial
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NGN Capital frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 4
LH
North America, New York, United States, New York
Co-Investments: 3
3i Group
Europe, England, United Kingdom, London
Co-Investments: 6
EGS Healthcare Capital Partners
North America, Connecticut, United States, Norwalk
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 5
Arcus Ventures
North America, New York, United States, New York
Co-Investments: 4
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 3
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 4
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 3
MedVenture Associates
North America, California, United States, Emeryville
Co-Investments: 5

What are some of recent deals done by NGN Capital?

Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series CJul 24, 2017
Amount Raised: $30,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BJan 7, 2016
Amount Raised: $16,000,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BSep 2, 2015
Amount Raised: $17,600,000
Exosome Diagnostics

New York, New York, United States

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

BiotechnologyGeneticsHealth CareHealth Diagnostics
Series BMar 11, 2014
Amount Raised: $27,000,000
PIN Pharma

New York, New York, United States

PIN Pharma is a biopharmaceutical company

BiotechnologyPharmaceutical
Series AJan 1, 2014
Amount Raised: $6,750,000
Endosense

Geneva, Geneve, Switzerland

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CNov 27, 2013
Amount Raised: $41,185,254
Endosense

Geneva, Geneve, Switzerland

Endosense is a medical tech company focused on improving the reproducibility of catheter ablation for the treatment of cardiac arrhythmias.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CNov 27, 2012
Amount Raised: $40,300,000
Cerapedics

Westminster, Colorado, United States

CeraPedics is a medical device company that focuses on developing and commercializing novel osteobiologic products.

BiotechnologyHealth CareMedical Device
Series CJul 23, 2012
Amount Raised: $19,000,000
Small Bone Innovations

Morrisville, Pennsylvania, United States

Small Bones Innovations makes devices for small bones and joints, particularly focusing on trauma and arthroplasty.

Health CareMedicalPharmaceutical
Series FDec 17, 2010
Amount Raised: $15,000,000
Artisan Pharma

Waltham, Massachusetts, United States

Artisan Pharma provides critical-care and hospital-based therapeutics to patients, treating physicians, and payors.

BiotechnologyHealth CareHospitalTherapeutics
Series CJul 20, 2010
Amount Raised: $3,000,000